Pulmonary Hypertension

severe pah in heart :: Article Creator Treating Pulmonary Arterial Hypertension Pulmonary arterial hypertension (PAH) is one of five types of pulmonary hypertension. It happens when the blood vessels in your lungs narrow and scar so much that it's hard for blood to move through them. This can trigger high blood pressure in the lungs. PAH can be hard to diagnose. That's because the symptoms – like shortness of breath – are common to several other medical conditions. There's no cure. But there are FDA-approved treatments. Here's what you need to know. How Is Pulmonary Arterial Hypertension Treated? What caused your PAH, the symptoms, and how advanced your condition is all impact what treatment might work best for you. It may take time to figure out, but your doctor is there to help. Options include: Medications Surgery Oxygen therapy Calcium channel blockers Blood thinners Diet changes Exercise What Medications C

atelectasis copd :: Article Creator Vitamins By Condition Learn about User Reviews and read IMPORTANT information about user generated content Conditions of Use and Important Information: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you. This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is e

mean pulmonary artery pressure formula :: Article Creator

stages of interstitial lung disease :: Article Creator Interstitial Lung Disease Highly Prevalent In Late-stage Systemic Sclerosis Patients: Study A new study published in the journal of Arthritis & Rheumatology showed that interstitial lung disease (ILD) can occur in people with late-stage systemic sclerosis (SSc). Systemic sclerosis is a clinically diverse illness marked by intricate interactions between fibrosis, vasculopathy, and immunity. The skin, gastrointestinal tract, lungs, kidneys, and heart are among the organ systems that are impacted by this. Up to 60% of the mortality linked to SSc is caused by the two most prevalent pulmonary manifestations of the illness, interstitial lung disease and pulmonary arterial hypertension (PAH). ILD in patients with SSc is usually characterized by bilateral, ground-glass opacities, lower-lobe predominant reticulations, and occasionally honeycombing when seen on high-resolution computed tomog

total anomalous pulmonary venous connection :: Article Creator Two-Month-Old Baby Treated For Rare Heart Condition At KIMS Cuddles Hospital Visakhapatnam: A two-month-old baby weighing 2.7 kilograms was successfully treated for a rare, and life-threatening heart condition, Total Anomalous Pulmonary Venous Connection (TAPVC), at KIMS Cuddles Hospital in Visakhapatnam. The baby was brought to the hospital in a critical condition, with an oxygen saturation level dangerously low at 43%. TAPVC is a congenital heart defect where the veins bringing oxygen-rich blood from the lungs do not connect normally to the heart. Instead of flowing to the left side Attrium of the heart to be pumped out to the body, the blood flows into the right side, where oxygen-poor and oxygen-rich blood mix. As a result, the baby's body wasn't receiving enough oxygenated blood, putting his life in grave danger. Dr. Nikhil Tenneti, Chief Neonatologist at KIMS

dr shukla pulmonologist :: Article Creator

severe pulmonic stenosis :: Article Creator TCT 1164: Severe Pulmonary Hypertension In Rheumatic Mitral Stenosis Drastically Reduced By Percutaneous Mitral Comissurotomy State Zip Country SUPRAVALVULAR AORTIC STENOSIS WITHOUT WILLIAMS SYNDROME Supravalvular aortic stenosis (SVAS) is the major cardiac lesion of Williams Syndrome (WS). WS also has features of mental retardation (MR), characteristic facies and variable hypercalcemia in infancy. Most cases of WS probably represent new autosomal dominant (AD) mutations. Isolated SVAS ± peripheral pulmonic stenosis can occur sporadically, however, when reported to occur in more than one family member, it has been assumed by some (McKusick #19405) to be a mild expression of WS. This has major implications for genetic counseling, cardiac evaluation and for the prognosis of the patient and family. We evaluated 21 members of a 3-generation, 34-member family in which 12 have SVAS documented by ultras